Lisata Therapeutics, Inc.
LSTA
$1.09
-$0.04-3.54%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 22.73% | 15.31% | 17.01% | 12.04% | 10.19% |
| Total Depreciation and Amortization | -62.35% | -38.60% | -16.09% | -4.44% | -8.11% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7.71% | 16.82% | 33.89% | 49.09% | 103.46% |
| Change in Net Operating Assets | -28.45% | 10,800.00% | -47.42% | -195.67% | 376.16% |
| Cash from Operations | 24.88% | 23.13% | 17.60% | 8.83% | 17.82% |
| Capital Expenditure | 100.00% | 100.00% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2.02% | -65.21% | 14.21% | 169.22% | -79.55% |
| Cash from Investing | 2.59% | -65.15% | 14.00% | 168.76% | -79.67% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 180.91% | 237.50% | 1,152.94% | 1,119.64% | 489.29% |
| Repurchase of Common Stock | 58.70% | 54.93% | 7.66% | -171.13% | -160.14% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1,496.36% | 1,022.99% | 390.78% | 446.51% | 40.22% |
| Foreign Exchange rate Adjustments | 168.42% | 650.00% | 120.00% | 15.15% | 36.67% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 44.21% | -350.69% | 96.04% | 96.04% | -348.92% |